EXHIBIT 10.4 COMMONWEALTH BIOTECHNOLOGIES, INC. WARRANT AGREEMENT June 25, 1997 Mr. Thomas R. Reynolds 911 East Leigh Street, Suite G-19 Richmond, Virginia 23219 Dear Sir: Commonwealth Biotechnologies, Inc., a Virginia corporation (the "Company"),...Warrant Agreement • October 7th, 1997 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
EXHIBIT 10.2 COMMONWEALTH BIOTECHNOLOGIES, INC. WARRANT AGREEMENT Anderson & Strudwick, Incorporated 1108 E. Main Street Richmond, Virginia 23219 Ladies and Gentlemen: Commonwealth Biotechnologies, Inc., a Virginia corporation (the "Company"), agrees...Warrant Agreement • October 7th, 1997 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
ANDLoan Agreement • April 6th, 1998 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
COMMONWEALTH BIOTECHNOLOGIES, INC. (a Virginia corporation) 1,015,000 Shares of Common Stock ($6.00 per share) UNDERWRITING AGREEMENT Anderson & Strudwick, Incorporated 1108 E. Main Street Richmond, Virginia 23219 Ladies and Gentlemen: The...Underwriting Agreement • October 14th, 1997 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
EXHIBIT 10.5 COMMONWEALTH BIOTECHNOLOGIES, INC. WARRANT AGREEMENT June 25, 1997 Mr. Gregory A. Buck 911 East Leigh Street, Suite G-19 Richmond, Virginia 23219 Dear Sir: Commonwealth Biotechnologies, Inc., a Virginia corporation (the "Company"), agrees...Warrant Agreement • October 7th, 1997 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
Exhibit 10.2 THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR...Warrant Agreement • September 26th, 2002 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
COMMON STOCK PURCHASE WARRANT HEDGEPATH PHARMACEUTICALS, INC.Common Stock Purchase Warrant • February 23rd, 2016 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on , 2021 (the “Termination Date”) but not thereafter, to subscribe for and purchase from HedgePath Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
ESCROW AGREEMENTEscrow Agreement • October 7th, 1997 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
EXHIBIT 1.2 COMMONWEALTH BIOTECHNOLOGIES, INC. $3,000,000 Convertible Subordinated Notes SELECTED DEALER AGREEMENT Dear Sirs: 1. We have agreed to sell, as placement agent for the issuer on a best efforts all-or-none basis, 834,000 shares of Common...Selected Dealer Agreement • July 21st, 1997 • Commonwealth Biotechnologies Inc • Virginia
EXHIBIT 10.8 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT made as of the 25th day of June, 1997, by and between COMMONWEALTH BIOTECHNOLOGIES, INC., a Virginia corporation (the "Employer"), and Thomas R. Reynolds (the "Executive"). In consideration of the...Employment Agreement • October 7th, 1997 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
Exhibit 10.1 COMMON STOCK AND WARRANT PURCHASE AGREEMENT THIS COMMON STOCK AND WARRANT PURCHASE AGREEMENT (this "Agreement") is made as of August 30, 2002, by and between Commonwealth Biotechnologies, Inc., a Virginia corporation (the "Company"), and...Common Stock and Warrant Purchase Agreement • September 26th, 2002 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
SUBSCRIPTION AGREEMENTSubscription Agreement • June 23rd, 2009 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • New York
THIS SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of June 22, 2009, by and among Commonwealth Biotechnologies, Inc., a Virginia corporation (the “Company”), and the subscribers identified on the signature page hereto (each a “Subscriber” and collectively “Subscribers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 15th, 2016 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research • Florida
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of , 2016, between HedgePath Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto, whether such purchaser is or becomes a signature as of the Initial Closing or any Subsequent Closing (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Exhibit 10.3 THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR...Warrant Agreement • September 26th, 2002 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
No. ___ _________ Shares COMMONWEALTH BIOTECHNOLOGIES, INC. COMMON STOCK PURCHASE WARRANT NEITHER THIS SECURITY NOR ANY SECURITY FOR WHICH IT MAY BE EXERCISED HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR...Common Stock Purchase Warrant • October 7th, 1997 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research
THIS IS TO CERTIFY that ____________________ or his assigns as permitted in that certain Warrant Agreement (the "Warrant Agreement") dated June 25, 1997 between the Company (as hereafter defined) and __________________ is entitled to purchase at any time or from time to time on or after June 25, 1998 until 5:00 p.m., Richmond, Virginia time on June 25, 2007, ______ shares of Common Stock of Commonwealth Biotechnologies, Inc., a Virginia corporation (the "Company"), for an exercise price per share as set forth in the Warrant Agreement referred to herein. This Warrant is issued pursuant to the Warrant Agreement, and all rights of the holder of this Warrant are further governed by, and subject to the terms and provisions of such Warrant Agreement, copies of which are available upon request to the Company. The holder of this Warrant and the shares issuable upon the exercise hereof shall be entitled to the benefits, rights and privileges and subject to the obligations, duties and liabilitie
INHIBITOR THERAPEUTICS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • December 19th, 2022 • Inhibitor Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Employment Agreement (the “Agreement”), entered into as of December 13, 2022 (the “Effective Date”), is made by and between Inhibitor Therapeutics, Inc., a Delaware corporation (the “Company”) and Francis E. O’Donnell (“Executive” and, together with the Company, the “Parties”).
EXHIBIT 10.10 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT made as of the 25th day of June, 1997, by and between COMMONWEALTH BIOTECHNOLOGIES, INC., a Virginia corporation (the "Employer"), and Robert B. Harris, Ph.D. (the "Executive"). In consideration...Employment Agreement • October 7th, 1997 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
Exhibit 10.2 ------------ THIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION...Warrant Agreement • June 5th, 2002 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
SECURITY AGREEMENTSecurity Agreement • January 8th, 2008 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • New York
EXHIBIT 10.1 COMMONWEALTH BIOTECHNOLOGIES, INC. (a Virginia corporation) $3,000,000 Subordinated Convertible Notes (Minimum purchase of $50,000) PLACEMENT AGREEMENT June 17, 1997 Anderson & Strudwick, Incorporated 1108 E. Main Street Richmond,...Placement Agreement • July 21st, 1997 • Commonwealth Biotechnologies Inc • Virginia
No. _________ 101,500 Shares COMMONWEALTH BIOTECHNOLOGIES, INC. COMMON STOCK PURCHASE WARRANT THIS IS TO CERTIFY that ANDERSON & STRUDWICK, INCORPORATED or its assigns as permitted in that certain Warrant Agreement (the "Warrant Agreement") dated...Common Stock Purchase Warrant • October 7th, 1997 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research
THIS IS TO CERTIFY that ANDERSON & STRUDWICK, INCORPORATED or its assigns as permitted in that certain Warrant Agreement (the "Warrant Agreement") dated ___________, 1997 between the Company (as hereafter defined) and Anderson & Strudwick, Incorporated is entitled to purchase at any time or from time to time on or after ____________, 1998 until 5:00 p.m., Richmond, Virginia time on ___________, 2002, 101,500 shares of Common Stock of Commonwealth Biotechnologies, Inc., a Virginia corporation (the "Company"), for an exercise price per share as set forth in the Warrant Agreement referred to herein. This Warrant is issued pursuant to the Warrant Agreement, and all rights of the holder of this Warrant are further governed by, and subject to the terms and provisions of such Warrant Agreement, copies of which are available upon request to the Company. The holder of this Warrant and the shares issuable upon the exercise hereof shall be entitled to the benefits, rights and privileges and subje
Exhibit 10.17 OFFICER'S SEVERANCE AGREEMENT This Agreement ("Agreement") is entered into as of April 10, 2000 between Commonwealth Biotechnologies, Inc., a Virginia corporation (the "Company"), and James R Brennan (the "Officer"). 1. Purpose. The...Severance Agreement • March 31st, 2003 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
Exhibit 10.16 COMMONWEALTH BIOTECHNOLOGIES, INC. INCENTIVE STOCK OPTION AGREEMENT THIS AGREEMENT, dated as of the ____________, 1997, between COMMONWEALTH BIOTECHNOLOGIES, INC., a Virginia corporation (the "Company"), and _____________ ("Optionee"),...Incentive Stock Option Agreement • October 7th, 1997 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 23rd, 2016 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research • Florida
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of , 2016, between HedgePath Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto, whether such purchaser is or becomes a signature as of the Initial Closing or any Subsequent Closing (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
EXHIBIT 10.13 EXECUTIVE SEVERANCE AGREEMENT This Agreement ("Agreement") is entered into as of June 25, 1997 between Commonwealth Biotechnologies, Inc., a Virginia corporation (the "Company"), and Gregory A. Buck, Ph.D. (the "Executive"). 1. Purpose....Executive Severance Agreement • October 7th, 1997 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
INHIBITOR THERAPEUTICS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • December 19th, 2022 • Inhibitor Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Employment Agreement (the “Agreement”), entered into as of December 13, 2022 (the “Effective Date”), is made by and between Inhibitor Therapeutics, Inc., a Delaware corporation (the “Company”) and James A. McNulty (“Executive” and, together with the Company, the “Parties”).
Exhibit 10.16 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT made as of December 1, 1997, by and between COMMONWEALTH BIOTECHNOLOGIES, INC., a Virginia corporation (the "Employer"), and James H. Brennan (the "Employee"). In consideration of the mutual...Employment Agreement • March 31st, 2003 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
EXHIBIT 10.12 EXECUTIVE SEVERANCE AGREEMENT This Agreement ("Agreement") is entered into as of June 25, 1997 between Commonwealth Biotechnologies, Inc., a Virginia corporation (the "Company"), and Thomas R. Reynolds (the "Executive"). 1. Purpose. The...Executive Severance Agreement • October 7th, 1997 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
EMPLOYMENT AGREEMENTEmployment Agreement • April 9th, 2008 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
THIS EMPLOYMENT AGREEMENT made as of the 1st day of January, 2007, by and between COMMONWEALTH BIOTECHNOLOGIES, INC., a Virginia corporation (the “Employer”), and THOMAS R. REYNOLDS (the “Executive”).
SECURITIES PURCHASE AGREEMENT Dated January 8, 2018 by and between HEDGEPATH PHARMACEUTICALS, INC. and MAYNE PHARMA VENTURES PTY LTDSecurities Purchase Agreement • January 11th, 2018 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research • Delaware
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into this 8th day of January, 2018 (the “Signing Date”), by and between MAYNE PHARMA VENTURES PTY LTD, an Australian company ACN 168 896 357 (“Mayne Pharma”) and HEDGEPATH PHARMACEUTICALS, INC., a Delaware corporation (“HPPI”).
FOIA CONFIDENTIAL TREATMENT REQUEST BY HEDGEPATH PHARMACEUTICALS, INC. IRS EMPLOYER IDENTIFICATION NUMBER 30-0793665 Confidential treatment requested with respect to certain portions hereof denoted with “***” ***CONFIDENTIAL TREATMENT REQUESTED***...Employment Agreement • September 9th, 2014 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research • Delaware
THIS EMPLOYMENT AGREEMENT (the “Agreement”) dated as of September 4, 2014 (the “Effective Date”), is by and between HedgePath Pharmaceuticals, Inc., a Delaware corporation, with its principal place of business at 324 South Hyde Park Avenue, Tampa FL 33606 (the “Company”) and Garrison J. Hasara (the “Executive”).
SUBSCRIPTION AGREEMENTSubscription Agreement • June 4th, 2004 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • New York
THIS SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of May 27, 2004, by and among Commonwealth Biotechnologies, Inc., a Virginia corporation (the “Company”), and the subscribers identified on the signature page hereto (each a “Subscriber” and collectively “Subscribers”).
SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • August 6th, 2008 • Commonwealth Biotechnologies Inc • Services-commercial physical & biological research • Virginia
THIS SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT made as of the 31st day of July, 2008, by and between COMMONWEALTH BIOTECHNOLOGIES, INC., a Virginia corporation (the “Employer”), and JAMES H. BRENNAN (the “Employee”).
DEBT FORGIVENESS AGREEMENTDebt Forgiveness Agreement • June 30th, 2014 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research • Delaware
THIS DEBT FORGIVENESS AGREEMENT (this “Agreement”) is made and entered into and effective as of this 24th day of June, 2014 by and between HEDGEPATH PHARMACEUTICALS, INC., a Delaware corporation (“HPPI”), and HEDGEPATH, LLC a Delaware limited liability company (“HP LLC”).
CONFIDENTIAL TREATMENT REQUESTED*** Note: Confidential treatment requested with respect to certain portions hereof denoted with December 17, 2018 AMENDED AND RESTATED SUBLICENSE AGREEMENT BETWEEN MAYNE PHARMA INTERNATIONAL PTY LTD HEDGEPATH...Sublicense Agreement • March 7th, 2019 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research • Maryland
THIS AMENDED AND RESTATED SUBLICENSE AGREEMENT (this “Agreement”) is entered into effective as of December 17, 2018 by and between MAYNE PHARMA INTERNATIONAL PTY LTD, ABN 88 007 870 984, an Australian body corporate having an address at 1538 Main North Road, Salisbury South, SA 5106, Australia (“Mayne Pharma”), and HEDGEPATH PHARMACEUTICALS, INC., a company incorporated in Delaware having an address at 324 South Hyde Park Avenue #350, Tampa, Florida, 33606, United States (“HPPI”) with respect to the following:
